The invariant chain p35 isoform promotes formation of nonameric complexes with MHC II molecules

Immunology and Cell Biology

Volumn 92, Issue 6, 2014, Pages 553-556

  Cloutier, Maryse ^a   Gauthier, Catherine ^a   Fortin, Jean Simon ^a   Thibodeau, Jacques ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HETERODIMER; LYSINE; MYC PROTEIN; PROTEIN P35; B LYMPHOCYTE ANTIGEN; HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DR ANTIGEN; INVARIANT CHAIN; ISOPROTEIN;

ARTICLE; CONTROLLED STUDY; CYTOPLASM; ENDOPLASMIC RETICULUM; GENE EXPRESSION; MAJOR HISTOCOMPATIBILITY COMPLEX; MAJOR HISTOCOMPATIBILITY COMPLEX II; MOLECULAR INTERACTION; STOICHIOMETRY; SURFACE PROPERTY; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; HUMAN; IMMUNOLOGY; PROTEIN MOTIF;

AMINO ACID MOTIFS; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; ENDOPLASMIC RETICULUM; GENE EXPRESSION REGULATION; HEK293 CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; PROTEIN ISOFORMS;

EID: 84904044378     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2014.17     Document Type: Article

References (24)

1. Cresswell P. Invariant chain structure and MHC class II function. Cell 1996; 84: 505-507. (Pubitemid 26071731)
2. Strubin M, Berte C, Mach B. Alternative splicing and alternative initiation of translation explain the four forms of the Ia antigen-associated invariant chain. EMBO J 1986; 5: 3485-3488.
3. Roche PA, Marks MS, Cresswell P. Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain. Nature 1991; 354: 392-394. (Pubitemid 21896847)
4. Lamb CA, Cresswell P. Assembly and transport properties of invariant chain trimers and HLA-DR-invariant chain complexes. J Immunol 1992; 148: 3478-3482.
5. Strubin M, Long EO, Mach B. Two forms of the Ia antigen-associated invariant chain result from alternative initiations at two in-phase AUGs. Cell 1986; 47: 619-625. (Pubitemid 17215351)
6. Schutze M-P, Peterson PA, Jackson MR. An N-terminal double-arginine motif maintains type II membrane proteins in the endoplasmic reticulum. EMBO J 1994; 13: 1696-1705. (Pubitemid 24114722)
7. Khalil H, Brunet A, Saba I, Terra R, Sekaly RP, Thibodeau J. The MHC class II beta chain cytoplasmic tail overcomes the invariant chain p35-encoded endoplasmic reticulum retention signal. Int Immunol 2003; 15: 1249-1263. (Pubitemid 37220498)
8. Singer PA, Lauer W, Dembic Z, Mayer WE, Lipp J, Koch N et al. Structure of the murine Ia-associated invariant (Ii) chain as deduced from a cDNA clone. EMBO J 1984; 3: 873-877.
9. Cresswell P. Chemistry and functional role of the invariant chain. Curr Opin Immunol 1992; 4: 87-92.
10. Riberdy JM, Newcomb JR, Surman MJ, Barbosa JA, Cresswell P. HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides. Nature 1992; 360: 474-477.
11. Denzin LK, Cresswell P. HLA-DM induces CLIP dissociation from MHC class II ab dimers and facilitates peptide loading. Cell 1995; 82: 155-165.
12. Majera D, Kristan KC, Neefjes J, Turk D, Mihelic M. Expression, purification and assembly of soluble multimeric MHC class II-invariant chain complexes. FEBS Lett 2012; 586: 1318-1324.
13. Koch N, Zacharias M, Konig A, Temme S, Neumann J, Springer S. Stoichiometry of HLA class II-invariant chain oligomers. PLoS One 2011; 6: e17257.
14. Teasdale RD, Jackson MR. Signal-mediated sorting of membrane proteins between the endoplasmic reticulum and the golgi apparatus. Annu Rev Cell Dev Biol 1996; 12: 27-54. (Pubitemid 26422708)
15. Khalil H, Brunet A, Thibodeau J. A three-amino-acid-long HLA-DRbeta cytoplasmic tail is sufficient to overcome ER retention of invariant-chain p35. J Cell Sci 2005; 118: 4679-4687. (Pubitemid 41646378)
16. Anderson HA, Bergstralh DT, Kawamura T, Blauvelt A, Roche PA. Phosphorylation of the invariant chain by protein kinase C regulates MHC class II trafficking to antigen-processing compartments. J Immunol 1999; 163: 5435-5443.
17. Kuwana T, Peterson PA, Karlsson L. Exit of major histocompatibility complex class II-invariant chain p35 complexes from the endoplasmic reticulum is modulated by phosphorylation. Proc Natl Acad Sci USA 1998; 95: 1056-1061. (Pubitemid 28124911)
18. Marks MS, Blum JS, Cresswell P. Invariant chain trimers are sequestered in the rough endoplasmic reticulum in the absence of association with HLA class II antigens. J Cell Biol 1990; 111: 839-855.
19. Warmerdam PA, Long EO, Roche PA. Isoforms of the invariant chain regulate transport of MHC class II molecules to antigen processing compartments. J Cell Biol 1996; 133: 281-291. (Pubitemid 26132530)
20. Jasanoff A, Song S, Dinner AR, Wagner G, Wiley DC. One of two unstructured domains of Ii becomes ordered in complexes with MHC class II molecules. Immunity 1999; 10: 761-768. (Pubitemid 29302929)
21. van LM, McEwen-Smith RM, Benham AM. HLA-DP HLA-DQ, and HLA-DR have different requirements for invariant chain and HLA-DM. J Biol Chem 2010; 285: 40800-40808.
22. Veenstra H, Jacobs P, Dowdle EB. Processing of HLA-class II invariant chain and expression of the p35 form is different in malignant and transformed cells. Blood 1993; 82: 2494-2500. (Pubitemid 23304274)
23. Yan G, Shi L, Penfornis A, Faustman DL. Impaired processing and presentation by MHC class II proteins in human diabetic cells. J Immunol 2003; 170: 620-627. (Pubitemid 36026191)
24. Faubert A, Samaan A, Thibodeau J. Functional analysis of tryptophans alpha 62 and beta 120 on HLA-DM. J Biol Chem 2002; 277: 2750-2755. (Pubitemid 34953304)